Cagrilintide/semaglutide
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
Novo Nordisk · Phase 3 · Withdrawn · Enrollment 0
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.